Dr. Bardon is the Founder and Portfolio Manager for Burrage Capital and a Partner of the MPM – UBS Oncology Impact Fund. Previously, Dr. Bardon was an equity analyst at Pyramis Global Advisors of Fidelity. Dr. Bardon received her MD from Harvard Medical School and completed a residency in internal medicine at the Brigham and Women’s Hospital. While at Harvard Medical School, she was the recipient of a Howard Hughes Medical Institute fellowship where she conducted genetic research in immunology. Dr. Bardon also received an MBA from Harvard Business School. She currently serves on the Board of Fellows at Harvard Medical School.